Terapias Avanzadas para Enfermedades Hepáticas Raras
AAV4Cancer
Universidad Autónoma de Madrid
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Universidad Autónoma de Madrid (7)
2023
-
Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver
Molecular Genetics and Metabolism Reports, Vol. 35
-
Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)
Bone Marrow Transplantation
-
Treatment with the senolytics dasatinib/quercetin reduces SARS-CoV-2-related mortality in mice
Aging Cell, Vol. 22, Núm. 3
2018
-
Priming of dendritic cells by DNA-containing extracellular vesicles from activated T cells through antigen-driven contacts
Nature Communications, Vol. 9, Núm. 1
2013
-
T cell costimulation with anti-CD137 monoclonal antibodies is mediated by K63-polyubiquitin-dependent signals from endosomes
Journal of Immunology, Vol. 190, Núm. 12, pp. 6694-6706
1997
-
Cloning of the gp63 surface protease of Leishmania infantum. Differential post-translational modifications correlated with different infective forms
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1361, Núm. 1, pp. 92-102
1993
-
Levamisole and interferon in children with chronic hepatitis B
Hepatology, Vol. 18, Núm. 2, pp. 264-269